Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.56 |
| ▸ | AKT1 | P31749 | 2/20 | 0.56 |
| ▸ | ESR1 | P03372 | 1/20 | 0.56 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.56 |
| ▸ | CDC25A | P30304 | 1/20 | 0.56 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.56 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.56 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.43 |
| ▸ | MEN1 | O00255 | 4/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.43 |
| ▸ | GMNN | O75496 | 3/20 | 0.43 |
| ▸ | BLM | P54132 | 3/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.43 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.43 |
| ▸ | PRKCG | P05129 | 1/20 | 0.43 |
| ▸ | PRKCB | P05771 | 1/20 | 0.43 |
| ▸ | PRKCA | P17252 | 1/20 | 0.43 |
| ▸ | PRKCH | P24723 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1856364 | 0.88 | LMNA (0.51) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL18894366 | 0.84 | LMNA (0.57) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL2118767 | 0.82 | SMN1; SMN2 (0.47) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL29613186 | 0.81 | LMNA (0.64) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL29613185 | 0.81 | LMNA (0.64) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL9067683 | 0.81 | LMNA (0.54) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL9651737 | 0.80 | LMNA (0.67) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL9649661 | 0.80 | LMNA (0.67) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL9650951 | 0.80 | LMNA (0.67) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL11372894 | 0.80 | LMNA (0.58) | LMNAAKT1ESR1ADORA3CDC25A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 308 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4312951-A1 | IMPLANTABLE MEDICAL DEVICE FOR THE DELIVERY OF NUCLEIC ACID-ENCAPSULATED PARTICLES | Celanese EVA Performance Polymers LLC (US) | 2024-02-07 | — | — | EP | claimed |
| US-20220313616-A1 | Implantable Medical Device for the Delivery of Nucleic Acid-Encapsulated Particles | CELANESE EVA PERFORMANCE POLYMERS LLC | 2022-10-06 | — | — | US | claimed |
| EP-2131870-B1 | Magnetic resonance imaging contrast agents comprising zinc-containing magnetic metal oxide nanoparticles | UNIV YONSEI IACF (KR) | 2016-03-16 | — | — | EP | claimed |
| US-20150196589-A1 | FORMULATIONS FOR ALTERATION OF BIOPHYSICAL PROPERTIES OF MUCOSAL LINING | PULMATRIX, INC. | 2015-07-16 | — | — | US | claimed |
| US-8801955-B2 | Water-soluble nanoparticles stabilized with multi-functional group ligands and method of preparation thereof | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) | 2014-08-12 | — | — | US | claimed |
| US-8722648-B2 | Liquid pharmaceutical form of alkylphosphocholine and method for preparing same | MENG PAUL (AT) | 2014-05-13 | — | — | US | claimed |
| US-8703179-B2 | Mucosal formulation | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2014-04-22 | — | — | US | claimed |
| US-20130020526-A1 | Water-Soluble Nanoparticles Stabilized with Multi-Functional Group Ligands and Method of Preparation Thereof | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) | 2013-01-24 | — | — | US | claimed |
| EP-2451460-A1 | LIQUID PHARMACEUTICAL FORM OF ALKYLPHOSPHOCHOLINE AND METHOD OF PREPARING SAME | Expergen Drug Development GmbH (AT) | 2012-05-16 | — | — | EP | claimed |
| US-20120115814-A1 | Liquid Pharmaceutical Form Of Alkylphosphocholine And Method For Preparing Same | EXPERGEN DRUG DEVELOPMENT GMBH (AT) | 2012-05-10 | — | — | US | claimed |
| US-20070053844-A1 | FORMULATIONS FOR ALTERATION OF BIOPHYSICAL PROPERTIES OF MUCOSAL LINING | PULMATRIX INC. | 2007-03-08 | — | — | US | claimed |
| CN-1302780-C | Use of alkyl choline phosphoric acid for preparing medicine for treating tumor before and/or during preparation of antitumor drug | ZENTARIS GMBH (DE) | 2007-03-07 | — | — | CN | claimed |
| WO-2006125153-A2 | FORMULATIONS FOR ALTERATION OF BIOPHYSICAL PROPERTIES OF MUCOSAL LINING | PULMATRIX INC. (US) | 2006-11-23 | — | — | WO | claimed |
| WO-2006025627-A1 | WATER-SOLUBLE NANOPARTICLES STABILIZED WITH MULTI-FUNCTIONAL GROUP LIGANDS AND METHOD OF PREAPATION THEREOF | YONSEI UNIVERSITY (KR) | 2006-03-09 | — | — | WO | claimed |
| CN-1676125-A | Nano-level emulsion containing taxine or hard-soluble medicine | ZHANG HAO (CN) | 2005-10-05 | — | — | CN | claimed |
| CN-1671397-A | Combined application of alkyl choline phosphoric acid and antitumor drug | ZENTARIS GMBH (DE) | 2005-09-21 | — | — | CN | claimed |
| US-20040242543-A1 | Pharmaceutical formulation for preventing protozoal diseases | ZENTARIS AG (DE) | 2004-12-02 | — | — | US | claimed |
| US-20030216355-A1 | Process for preventing protozoal diseases | AETERNA ZENTARIS GMBH (DE) | 2003-11-20 | — | — | US | claimed |
| CN-1052878-C | Stabilised hexadecylphosphocholine solutions in glycerol alkyl ethers | ASTA MEDICAL AKTIENGESELLSCHAF (DE) | 2000-05-31 | — | — | CN | claimed |
| CN-1090174-A | Stabilisation HEXADECYL PHOSPHOCHOLINE solution in the glycerol alkyl ether | ASTA MEDICA AG (DE) | 1994-08-03 | — | — | CN | claimed |